Skip to main content
Caplight Logo









Protera Health

Protera Health

Private
Troy, MichiganHealthcare & Life Scienceshttps://www.proterahealth.com/

Last Round

Series A

Extension

Jul 28, 2021

Total Funding Raised

$10M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Protera Health is a healthcare company that provides a virtual, physician-led, multidisciplinary solution for musculoskeletal (MSK) care.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Healthcare Analytics, EHR & EMR

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

musculoskeletal careMSKvirtual physical therapytelehealthvalue-based carepatient-reported outcome measuresPROMdigital healthvirtual-first caredigital PTcare coordinationhealth coachingemployer health benefitshealthcare cost managementdigital health platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protera Health Comparables

Compare Protera Health with similar companies based on industry and business-model similarity.

Protera Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vori Health
91%
LainaHealth Inc.
81%
TailorCare
81%

Protera Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJul 28, 2021
Series AJun 10, 2020

Key People

Founding team and executive leadership

Eric Makhni

CEO, Co-Founder

Founding Team

Protera Health Investors

Notable investors and investment history

Protera Health investors
InvestorRounds
Start-Up ChileAccelerator
ICL Planet Startup HubSeries A Extension
Grupo BimboSeries A Extension
IndieBioAccelerator
Sofinnova PartnersSeries A Extension, Series A
SOSVSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 15, 2026

    Grew 21% QoQ, from 28 to 34 employees.

  • Aug 21, 2026

    Monthly visitors increased 128% MoM, reaching 5.8K.

Protera Health Filings

Explore SEC and related filing metadata, where available.

Protera Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Protera Health's valuation, stock price, and market status.

Is Protera Health a public or private company?

Protera Health is a private company.

What is the current stock price of Protera Health?

Protera Health is a private company, so its shares have no public market price. Caplight tracks Protera Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Protera Health worth (valuation)?

Valuation information for Protera Health is not publicly available.

Can I buy Protera Health stock?

Protera Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Protera Health's last funding round?

Protera Health's most recent funding round was Series A Extension on July 28, 2021.

Who are the main investors in Protera Health?

Key investors in Protera Health include IndieBio, Sofinnova Partners.

Will Protera Health IPO soon?

No public IPO plans have been announced for Protera Health.

How can I track Protera Health secondary market activity?

Caplight tracks bids, offers, and trades in Protera Health's shares on secondary markets.

Firmographic Details

HeadquartersTroy, Michigan
Employee Range25
Year Founded2021
Last FundingJul 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?